Bill > S1631

This bill, titled the "Restoring Safeguards for Dangerous Abortion Drugs Act," focuses on mifepristone, a medication used for medical abortions, and proposes several significant restrictions. The bill requires the Secretary of Health and Human Services to withdraw the current Risk Evaluation and Mitigation Strategy (REMS) for mifepristone and replace it with the exact strategy that was approved in June 2011, effectively reverting to an older, potentially more restrictive protocol. Additionally, the bill establishes a new federal tort provision that allows individuals to sue telehealth providers, pharmacies, or anyone who imports or transports mifepristone in violation of existing laws, with potential claims for compensatory and punitive damages if they experience physical or mental harm from using the medication. The bill also amends the Federal Food, Drug, and Cosmetic Act to ban the importation of mifepristone into the United States, including prohibiting mailing the drug directly to individuals. These provisions aim to significantly limit access to mifepristone by imposing stricter regulatory requirements, creating legal liability for providers, and preventing international importation of the medication.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/1631/all-info